miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway

(2012) I-Shan Hsieh et al.   CARCINOGENESIS

MicroRNAs in Stress Signaling and Human Disease

(2012) Joshua T. Mendell et al.   CELL

RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis

(2012) Fabienne Danhier et al.   MOLECULAR PHARMACEUTICS

Multifaceted Role of Neuropilins in Cancer

(2011) S. Rizzolio et al.   CURRENT MEDICINAL CHEMISTRY

The role of β3-integrins in tumor angiogenesis: context is everything

(2011) Stephen D Robinson et al.   CURRENT OPINION IN CELL BIOLOGY

MicroRNAs in an Oral Cancer Context – from Basic Biology to Clinical Utility

(2011) M. Gorenchtein et al.   JOURNAL OF DENTAL RESEARCH

Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling

(2011) Mathieu Bergé et al.   JOURNAL OF HEPATOLOGY

A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours

(2011) Benjamin Beck et al.   NATURE

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320

(2011) A. Bronisz et al.   NATURE CELL BIOLOGY

Tumor angiogenesis: molecular pathways and therapeutic targets

(2011) Sara M Weis et al.   NATURE MEDICINE

DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications

(2011) I González-Ramírez et al.   ORAL DISEASES

Advances and applications of oral cancer basic research

(2011) Sabrina Daniela da Silva et al.   ORAL ONCOLOGY

Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta

(2010) Yelena Glinka et al.   CARCINOGENESIS

MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT

(2010) Zhan Zhang et al.   CELL CYCLE

Low-Level Expression of MicroRNAs let-7d and miR-205 Are Prognostic Markers of Head and Neck Squamous Cell Carcinoma

(2009) Geoffrey Childs et al.   AMERICAN JOURNAL OF PATHOLOGY

MicroRNA function in cancer: oncogene or a tumor suppressor?

(2009) Sylvia K. Shenouda et al.   CANCER AND METASTASIS REVIEWS

MicroRNA-320 Is Involved in the Regulation of Cardiac Ischemia/Reperfusion Injury by Targeting Heat-Shock Protein 20

(2009) Xiao-Ping Ren et al.   CIRCULATION

MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor

(2009) J. Li et al.   CLINICAL CANCER RESEARCH

A microRNA component of the hypoxic response

(2008) R Kulshreshtha et al.   CELL DEATH AND DIFFERENTIATION

MicroRNA-320 EXPRESSION IN MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS AND ITS RELATIONSHIP WITH INSULIN-LIKE GROWTH FACTOR-1 IN TYPE 2 DIABETIC RATS

(2008) XH Wang et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Combined anti-proliferative and anti-angiogenic strategies for cancer

(2008) Jair Bar et al.   EXPERT OPINION ON PHARMACOTHERAPY

The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma

(2008) Lei Chen et al.   JOURNAL OF HEPATOLOGY

Neuropilin-1 in acute myeloid leukemia: Expression and role in proliferation and migration of leukemia cells

(2008) Lin Lu et al.   LEUKEMIA & LYMPHOMA

The Genomic Analysis of Erythrocyte microRNA Expression in Sickle Cell Diseases

(2008) Shao-Yin Chen et al.   PLoS One

A miRNA Signature of Prion Induced Neurodegeneration

(2008) Reuben Saba et al.   PLoS One

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

(2008) L.-X. Yan et al.   RNA